Literature DB >> 14631330

The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study.

B Balkau1, M Vernay, L Mhamdi, M Novak, D Arondel, S Vol, J Tichet, E Eschwège.   

Abstract

CONTEXT: In 2001 the "National Cholesterol and Education Program Expert Panel" gave a clinical definition of the metabolic syndrome. The frequency of this syndrome at baseline and its incidence and persistence at three years is studied in a French population.
SUBJECTS: 2109 men and 2184 women from the D.E.S.I.R. longitudinal cohort study (Data from an Epidemiological Study on the Insulin Resistance syndrome) in central-western France, aged 30 to 64 years, were examined at inclusion and three years later.
METHODS: Evaluation of the frequencies, incidences and persistence of the metabolic syndrome and its abnormalities. This syndrome is defined by the presence of three or more of five abnormalities: waist circumference > 102/88 cm (men/women); triglycerides > o r=1.69 mmol/l, HDL-cholesterol<1.04/1.29 mmol/l (men/women); systolic/diastolic blood pressure > or =130 and/or 85 mmHg; fasting plasma glucose > or =6.1 mmol/l.
RESULTS: At baseline, 10% of men and 7% of women had the metabolic syndrome. If the syndrome was defined to include a treatment in the abnormalities (for diabetes, hypertension, dyslipidemia), the syndrome frequencies increased to 16% and 11%. However only 12% and 8% respectively, had this syndrome both at inclusion and at three years. High blood pressure was the most frequent abnormality: 70% and 47% in men and women respectively, at inclusion. The most stable abnormality was high waist circumference (80% persisted), hyperglycaemia the least stable (60% persisted). Hyperinsulinaemia did not cluster closely with this syndrome.
CONCLUSIONS: The age-specific frequency of the syndrome is more than 2.5 times higher in the US than in this French cohort and this ratio increased with age. The higher frequencies of abdominal obesity and low HDL-cholesterol in women than in men suggest that these gender-specific thresholds may need to be refined.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14631330     DOI: 10.1016/s1262-3636(07)70067-8

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  39 in total

1.  Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis.

Authors:  T A Hillier; A Rousseau; C Lange; P Lépinay; M Cailleau; M Novak; E Calliez; P Ducimetière; B Balkau
Journal:  Diabetologia       Date:  2006-05-16       Impact factor: 10.122

2.  Cohort Profile: the French childhood cancer survivor study for leukaemia (LEA Cohort).

Authors:  Julie Berbis; Gérard Michel; André Baruchel; Yves Bertrand; Pascal Chastagner; François Demeocq; Justyna Kanold; Guy Leverger; Dominique Plantaz; Marilyne Poirée; Jean-Louis Stephan; Pascal Auquier; Audrey Contet; Jean-Hugues Dalle; Stéphane Ducassou; Virginie Gandemer; Patrick Lutz; Nicolas Sirvent; Marie-Dominique Tabone; Sandrine Thouvenin-Doulet
Journal:  Int J Epidemiol       Date:  2014-03-17       Impact factor: 7.196

3.  Noncirrhotic hepatocellular carcinoma: derivation from hepatocellular adenoma? Clinicopathologic analysis.

Authors:  Ta-Chiang Liu; Neeta Vachharajani; William C Chapman; Elizabeth M Brunt
Journal:  Mod Pathol       Date:  2013-09-20       Impact factor: 7.842

4.  Metabolic effects of telmisartan in spontaneously hypertensive rats.

Authors:  Yong-Qi Li; Hui Ji; Yi-Hua Zhang; Da-Yong Ding; Xiao-Lei Ye
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-20       Impact factor: 3.000

5.  The stability of metabolic syndrome in children and adolescents.

Authors:  Jennifer K Gustafson; Lisa B Yanoff; Benjamin D Easter; Sheila M Brady; Margaret F Keil; Mary D Roberts; Nancy G Sebring; Joan C Han; Susan Z Yanovski; Van S Hubbard; Jack A Yanovski
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

6.  Features of left ventricular hypertrophy in patients with metabolic syndrome with or without comparable blood pressure: a meta-analysis.

Authors:  Ning-Yin Li; Jing Yu; Xiao-Wei Zhang; Shi-Xiong Wang; Peng Chang; Qi Ding; Rui-Xin Ma; Qun-Fei Chen; Feng Zhao; Feng Bai
Journal:  Endocrine       Date:  2013-01-31       Impact factor: 3.633

7.  Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study.

Authors:  Cihangir Erem; Arif Hacihasanoglu; Orhan Deger; Murat Topbaş; Ilgin Hosver; Halil Onder Ersoz; Gamze Can
Journal:  Endocrine       Date:  2008-03-13       Impact factor: 3.633

8.  Waist circumference and obesity-related abnormalities in French and Cameroonian adults: the role of urbanization and ethnicity.

Authors:  L Fezeu; B Balkau; E Sobngwi; A-P Kengne; S Vol; P Ducimetiere; J-C Mbanya
Journal:  Int J Obes (Lond)       Date:  2010-01-12       Impact factor: 5.095

9.  The correlation between waist circumference and ESC cardiovascular risk score: data from the German metabolic and cardiovascular risk project (GEMCAS).

Authors:  Heribert Schunkert; Susanne Moebus; Jens Hanisch; Peter Bramlage; Elisabeth Steinhagen-Thiessen; Hans Hauner; Joachim Weil; Jürgen Wasem; Karl-Heinz Jöckel
Journal:  Clin Res Cardiol       Date:  2008-07-21       Impact factor: 5.460

10.  Instability in the diagnosis of metabolic syndrome in adolescents.

Authors:  Elizabeth Goodman; Stephen R Daniels; James B Meigs; Lawrence M Dolan
Journal:  Circulation       Date:  2007-04-09       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.